Bayer Beats Baycol FCA Suit

Law360, New York (July 19, 2012, 6:54 PM EDT) -- A Minnesota federal judge on Thursday tossed a suit from a former employee accusing Bayer AG of misrepresenting the risks of its cholesterol drug Baycol — which was pulled after 31 deaths were linked to its use — and causing false claims to be submitted to Medicare.

U.S. District Judge Michael J. Davis dismissed with prejudice a second amended complaint by Laurie Simpson, a former Bayer senior market research analyst, finding that her False Claims Act allegations were not specific enough about which claims made to...
To view the full article, register now.